Skip to content

31 Urea combined with bifonazole is useful in the management of scalp psoriasis

To educate pharmacists about the different types of psoriasis and the current agents available for the management of this condition. Furthermore, it can be combined with anthralin to improve its clinical efficacy.31 Urea combined with bifonazole is useful in the management of scalp psoriasis.31 It is used topically in concentrations of 5 to 25 in creams or lotions and up to 40 in nail preparations. Guidelines of care for the management of psoriasis and psoriatic arthritis state that when used as a control in topical steroid trials, non-medicated topical moisturizers demonstrated a response rate ranging from 15 to 47 21, 27. The moisturizing action of urea in dry and scaly skin conditions has been widely studied and is well accepted 21, 38. From three small studies, limited evidence is known for an enhanced efficacy of other topical agents such as bifonazole, dithranol or betamethasone dipropionate and calcipotriol leading to a shortened treatment duration (see Table 3) 43 45. The treatment of scalp psoriasis is beset with problems of drug delivery, facial irritation, messy, time-consuming, cosmetically unacceptable applications and staining of hair. First phase involves descaling using salicylic acid or urea preparations. Corticosteroids, when combined with vitamin D analogs, minimize the irritation while the total amount of corticosteroids required is low. Combined with a corticosteroid cream under occlusion, it has been found useful for palmoplantar psoriasis.

31 Urea combined with bifonazole is useful in the management of scalp psoriasis 2The treatment of scalp psoriasis is beset with problems of drug delivery, facial irritation, messy, time-consuming, cosmetically unacceptable applications and staining of hair. First phase involves descaling using salicylic acid or urea preparations. Tazarotene has also been found to be efficacious in combination with topical steroids and calcipotriol. Combined with a corticosteroid cream under occlusion, it has been found useful for palmoplantar psoriasis. To avoid misdiagnosis as nail psoriasis, lichen planus, contact dermatitis, trauma, nail bed tumor or yellow nail syndrome, laboratory confirmation Bifonazole cream application after nail ablation with urea paste. Combination therapy for the treatment of immunoinflammatory disorders. The composition of claim 19, wherein said humectant is urea. 21. 31. The composition of claim 27, wherein said additional agent is a DMARD selected from methotrexate and leflunomide. Compounds useful in the invention include those described herein in any of their pharmaceutically acceptable forms, including isomers such as diastereomers and enantiomers, salts, esters, amides, thioesters, solvates, and polymorphs thereof, as well as racemic mixtures and pure isomers of the compounds described herein.

2 to 10 coal tar solution, are effective in scalp psoriasis. 31 32 33 34 35 36 37 38 39 40 Next Next. Q3.how would you manage a patient with acute MI? A3. Subject Adherence and Satisfaction for Treatment of Onychomycosis With Loceryl Nail Lacquer 5 Versus a Fungal Nail Treatment Set Containing Urea 40 Ointment and Bifonazole Cream 1 ClinicalTrials. This free news service SciBite.com, we hope you find it useful.

Bioline International Official Site (site Up-dated Regularly)

31 Urea combined with bifonazole is useful in the management of scalp psoriasis 3The use of antifungal nail lacquers in combination with oral agents, such as terbinafine and itraconazole, improves efficacy of antifungal therapy. Both were more effective than fluconazole and bifonazole against microconidia and chlamydospores as well as slightly more potent against chlamydospores and blastospores than terbinafine after 4 days of incubation and at concentrations of 10 g ml(-1). (HPCH) nail lacquer could improve the structure of the nail plates on psoriatic nails. Foamable composition combining a polar solvent and a hydrophobic carrier. The method of any of claim 25, 31 or 32, wherein the active agent comprises one or more herbal extracts. 6,126,920 ( the ‘920 Patent ) discloses treatment of various skin diseases, and in particular, scalp psoriasis, using a foamable pharmaceutical composition containing a corticosteroid active substance, an aliphatic alcohol, water, a fatty alcohol, a surface-active agent, a propellant and a buffering agent.

Loading